We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00376610
First Posted: September 15, 2006
Last Update Posted: July 4, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Frederiksberg University Hospital
  Purpose
ASR/Re-cap versus 28 MoM

Condition Intervention Phase
Bearings Device: ASR/Re-cap Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00376610


Locations
Denmark
Frederiksberg University Hospital
Frederiksberg, Copenhagen, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00376610     History of Changes
Other Study ID Numbers: KF1127957
First Submitted: September 14, 2006
First Posted: September 15, 2006
Last Update Posted: July 4, 2007
Last Verified: July 2007